Introduction Obesity is a major risk factor for mortality from a range of causes. We investigated whether skinfold measurements were associated with mortality independently of variation in body mass index (BMI). Methods A prospective analysis of mortality in 870 apparently healthy adult Caucasian men participating in an occupational health cohort was undertaken. At baseline, skinfold measurements were taken at biceps, triceps, iliac and subscapular sites. Derived measurements included the sum of all four skinfolds and subscapular to triceps, subscapular to iliac and BMI to iliac ratios. All-cause mortality was analysed by Cox proportional hazards modelling and death in specific mortality subcategories by competing risks analysis.
Introduction
Concern over the rapidly increasing prevalence of obesity throughout the world [1] has led to many studies correlating indices of obesity to long-term health. In particular, body mass index(BMI) has been found to be strongly associated with all-cause mortality [2, 3] and the development of chronic diseases including cardiovascular disease [4] , diabetes [5] , cancer [6] ,gallbladder diseases [7] and gout [8] . BMI is a commonly used measure of overall adiposity in clinical and research settings because of ease of measurement. However, there may be appreciable heterogeneity in risk at any given level of BMI. This is exemplified by the concept of "metabolically healthy obesity", according to which overweight or obese people with a relatively normal metabolic risk factor profile are at no greater cardiovascular risk than their normal weight equivalents [9, 10] . However, the metabolically healthy obese may show greater risk of progression to metabolic abnormality [11, 12] and, although risk of cardiovascular disease in metabolically healthy overweight or obese people may be less than in their metabolically unhealthy equivalents, with long follow-up [13] or in a sufficiently large sample [14] , an increase in cardiovascular risk may, nevertheless, be detected. Such heterogeneity in risk, independent of overall adiposity, may result from variation in the distribution of body fat. Obese people with a large depot of visceral fat appear to be at particularly high risk [15] [16] [17] [18] [19] and ectopic deposition of fat in liver, muscle or other tissues may also be important [20] . However, clinical evaluation of specific fat depots is limited by the need for computed tomography (CT) or magnetic resonance imaging (MRI) [21, 22] . Beyond measurement of BMI, clinical evaluation of adiposity-related risks may be enhanced by using alternative anthropometric measurements. Skinfold thickness measurements offer one such alternative but, hitherto, studies have not provided strong evidence to support their use in clinical practice. An increase in subscapular skinfold may not be associated with all-cause mortality in men [23] but has been found to be linked to ischaemic heart disease or variation in its risk factors in some studies [24, 25] , although not in all [26] . In the Paris Prospective Study, preferential localisation of fat in the abdominal component, as measured by sagittal diameter adjusted for the sum of trunk skinfolds was associated with increased cancer mortality [27] . Subscapular to triceps ratio has been found to be associated with stroke [28] , ischaemic heart disease [29] , and blood pressure [30] and has been proposed as a marker of central to peripheral fat distribution.
Appreciable covariation may be expected between skinfold thicknesses and overall adiposity and previous analyses may not have fully discriminated between risks associated with different measures of adiposity. The primary aim of the present analysis, therefore, was to investigate whether skinfold measurements were associated with mortality independently of BMI as an index of overall adiposity.
Subjects and methods

Participants
The Heart Disease and Diabetes Risk Indicators in a Screened Cohort (HDDRISC) study is a prospective study of 1192 white males recruited as part of a company health screening program undertaken in London, U.K. At enrolment, the participants were apparently healthy senior executives, working or recently retired. The study started in 1971 with participants invited for follow-up every 2-3 years; data collection ended in 2000. Skinfold thickness measurements were taken from the beginning of the study until 1996 and for the purposes of this analysis, only the participants with skinfold thickness measures (n = 888) were considered for inclusion. The present analysis is restricted to participants' earliest records with skinfold information. The study was approved by the ethics committee. All participants gave their written informed consent.
Measurements
Details of data recording have been described previously [31] . In brief, measurements were carried out at a dedicated metabolic day ward, in the morning following an overnight fast. Each participant provided a full medical history including details of smoking, alcohol consumption, exercise and medication and also underwent a range of clinical and laboratory measurements. Skinfold thicknesses were measured using the procedure of Durnin and Womersley [32] . The biceps skinfold was taken over the mid-point of biceps muscle with the arm resting supinated on the thigh. The triceps skinfold was taken over the mid-point of the triceps muscle, at the posterior line between the olecranon and tip of acromion. The subscapular skinfold was taken at an angle of about 45 degrees to the vertical, at the inferior angle of scapular and the iliac skinfold was taken just above the iliac crest in the mid-axillary line [32] . Skinfold thicknesses were measured three times at each of the four sites using Harpenden callipers. The mean of the three readings for each site was calculated.
Mortality ascertainment
Mortality information was obtained through the United Kingdom NHS Information Centre for Health and Social Care. Mortality information for participants who died overseas was notified by family members of the deceased or their employer. The mortality information was complete except for 18 participants who were no longer traceable. The present analysis includes deaths up to 1 January 2014 and follow-up time was calculated as the time between the earliest visit with skinfold information and death, or up till 1 January 2014 for those who were still alive. The primary endpoint was all cause mortality. The mortality causes were also subdivided into four categories; cancer deaths, arteriovascular deaths, infection deaths (predominantly pneumonia), and other deaths. Arteriovascular mortality comprised death from coronary heart disease, heart failure, cerebrovascular disease and aneurysm. Causes in the 'other death' category included motor neurone disease, respiratory disease, gastrointestinal ulceration, alcohol, and accident.
Data and statistical analysis
The following skinfold ratios were calculated: subscapular to triceps, subscapular to iliac, and BMI to iliac. In addition, the sum of all four skinfold thicknesses was calculated. Smoking was coded as 0, <15 (light) or ≥15 (heavy) cigarettes per day. Alcohol consumption was coded as 0, <28 units per week (light) or ≥28 units per week (heavy). Exercise habits were coded as none, moderate and regular (≥3 periods of ≥20 min of exercise to breathlessness per week). All data was analysed using STATA 13 for Windows (Stata, College Station, TX, USA). Baseline characteristics were expressed in median and interquartile range (IQR) for continuous variables and percentages and number of observations (n) for categorical variables. Significant differences between the survivors and non-survivors for continuous variables were assessed using Mann-Whitney test and for categorical variables by chi-square test. Triceps, subscapular, iliac, subscapular tricep ratio, subscapular iliac ratio, BMI iliac ratio and sum of skinfold thicknesses were logarithmically transformed to reduce heteroscedasticity in regression analyses. Continuous variables were standardised as z-scores for entry in univariable and multivariable analyses. The Cox proportional hazards model was used to analyse survival time in relation to all-cause mortality (STATA command: 'stcox') whereas competing-risks survival regression (STATA command: 'stcrreg') was used to analyse survival in the specific mortality subgroups: cancer, arteriovascular, infection and other. The Cox analysis proportional hazards assumption was checked using Schoenfeld residuals and linearity using Matingale residuals. For all models, linearity was further checked on the basis of hazard ratios in quartile and quintile percentiles of each skinfold. Effects significant at p < 0.05 were considered for interpretation.
Results
Out of 1192 participants in the HDDRISC study, 870 who had skinfold thicknesses measured and mortality follow-up data recorded were included for analysis. Of these, 303 participants died before 1 January 2014. There were 119 participants who died from cancer, 101 from arteriovascular disease, and 40 from infection. The remaining 43 participants died from other causes. The mean mortality follow-up time from the first record with skinfold information was 27.7 years with a range of 0.5-41.5 years.
At baseline, compared with survivors, those who died were older, had higher BMI, smoked more cigarettes and drank more alcohol (Table 1 ). These differences generally extended to the cancer, arteriovascular and infection mortality subgroups. Triceps and biceps skinfold thicknesses did not differ between survivors and those who died (Table 1) . Subscapular skinfold was higher among those who died of any cause (p = 0.01), specifically, those who died of arteriovascular disease (p = 0.02). Iliac skinfold was 16% lower (p < 0.001) among those who died of any cause (median 12.5 (IQR 8.6, 8.7) vs 14.9 (IQR 10.1, 21.5) mm in The statistical significances of differences between non-survivors and survivors are shown in superscript survivors). Iliac skinfold was also significantly lower among those who died of cancer (16% lower, p = 0.02), arteriovascular disease (13% lower, p = 0.008) and infection (31% lower, p = 0.001).
Variables in Table 1 that differed between survivors and those who died also generally showed associations with mortality in univariable survival analysis (results not shown). One exception was iliac skinfold, which were not significantly associated with all-cause, cancer, AVD and infection death in univariable survival analysis. However, in multivariable survival analysis, with age, BMI, smoking, alcohol and exercise as covariates, lower iliac skinfold was significantly, independently associated with all-cause, AVD and infective death ( Table 2) . No significant deviations from the Cox model proportionality and linearity assumptions were detected. Subscapular skinfold ceased to show any associations with mortality in multivariable analysis and, triceps and biceps skinfolds showed no associations with mortality. Bivariable survival analyses were undertaken to identify which variable was responsible for iliac skinfold emerging as a significant associate of mortality in multivariable analysis. The key variable was BMI: hazard ratios (95%CI, p) for iliac skinfold and BMI in bivariable analysis were: for all-cause mortality 0.76 (0.66,0.88, p < 0.001) and 1.51 (1.35,1.69, p < 0.001) respectively; for AVD mortality 0.75 (0.60,0.93, p = 0.009) and 1.44 (1.22,1.69, p < 0.001), respectively; and for infection mortality 0.64 (0.42,0.96, p = 0.03) and 1.27 (0.84,1.92, p = 0.2) respectively. Bivariable analysis also showed that group differences and univariable associations between subscapular skinfold and all-cause and AVD mortality were dependent on BMI (results not shown). Linearity checks based on hazard in skinfold percentiles found no evidence for J or U-shaped relationships between skinfolds and mortality. Nevertheless, an association was found between low triceps skinfold and all-cause mortality (lowest vs highest: quartile HR 1.51 (95%CI 1.07, 2.13) p = 0.02; quintile 1.73 (1.18,2.54) p = 0.005). However, this association did not extend to specific causes of mortality and was not enhanced in overweight or obesity.
The emergence of iliac skinfold as a strong negative associate of mortality when the positive associate of mortality, BMI, was included in survival analysis as an additional independent variable (plus the strengthening of the positive association between BMI and mortality) could result from a positive correlation between iliac skinfold and BMI. On Pearson correlation, BMI was found to explain 21% of the variation in iliac skinfold (R = 0.46, p < 0.001). There were, therefore, two components of variation in iliac skinfold, one positively related to mortality and dependent on BMI and one negatively related to mortality and independent of BMI. This unexpected finding suggested that risk of mortality associated with a low iliac skinfold might show differential associations with mortality at different BMI. We, therefore, derived the HR for all-cause mortality in iliac skinfold quartiles in ranges of BMI corresponding to normal weight (<25 kg/m 2 ), overweight (25-<30 kg/m 2 ) and obese (≥30 kg/m 2 ). Among normal weight participants, the lowest quartile of iliac skinfold was not associated with all-cause mortality (Fig. 1) , but was independently associated in the overweight (HR 2.07, p = 0.01) and risk was markedly increased in the obese (HR 6.34, p = 0.02). Numbers of deaths were relatively low among obese participants (n = 40). Therefore, variation in risk associated with low iliac skinfold was explored in successive ranges of overweight, both to include more participants and to identify at which level of BMI hazard substantially increased. Hazard ratios, HR (95%CI), associated with the lowest iliac skinfold quartile relative to the highest were for those with BMI > 25 kg/ 
Discussion
Skinfold thickness measures, including iliac skinfold, are positively related to BMI but the possibility that this relationship might obscure an underlying negative association between a skinfold measure and mortality appears to have been little appreciated. Our analysis of associations of skinfold thickness measures with mortality independently of variation in BMI has revealed that, in the cohort of men we studied, a low iliac skinfold is independently associated with increased mortality over the course of long-term follow-up, in particular, arteriovascular and infection mortality. Furthermore, risks associated with a low iliac skinfold appear to be particularly concentrated in the obese. Previous studies have emphasised a positive association between subscapular skinfold thickness and total or arteriovascular mortality risk [23, 25, 33] . Our study found some evidence for such an association, although not independently of BMI. Neither the Northwick Park Heart study [33] nor the Seven Countries Study of Cardiovascular Disease [23] took into account variation in BMI, although this was taken into account in the Caerphilly study. In contrast to our findings, the Caerphilly Study reported a relationship between subscapular skinfold and incident ischemic heart disease that was independent of BMI [25] . Of these previous studies, only the Northwick Park Heart study recorded iliac skinfold [33] , but BMI was not taken into account in exploring its associations with mortality and, in accord with our findings in univariate analysis, no association was apparent. Clearly, further prospective studies with measurement of iliac skinfold are needed to confirm or refute our findings and resolve existing inconsistencies.
In accord with other studies [2] [3] [4] 6] , our analysis found that BMI was positively associated with all-cause, cancer and arteriovascular mortality. However, BMI is a marker of overall adiposity [15] and skinfold measurements are generally taken to represent adiposity at different regional adipose tissue depots [34] . Truncal measurements (e.g., subscapular, abdominal and iliac) then represent central adiposity and peripheral measurements (e.g., biceps, triceps and thigh) peripheral adiposity. The importance given to this distinction stems from recognition of the role of the visceral fat depot in generating an adverse metabolic risk factor profile and augmenting long-term risk of chronic disease [21] . Given the way they are measured, variation in skinfold thicknesses necessarily reflect variation in subcutaneous fat and may relate only indirectly or not at all [35] to the visceral fat depot [34] . Nevertheless, skinfolds as indices of subcutaneous fat storage could be important given that a limited ability to store fat in subcutaneous depots may lead to redistribution of excess fatty acids to metabolically disruptive ectopic locations such as viscera, liver or muscle [18, 20] . Clinical evidence for an adverse effect of diminished subcutaneous fat comes from the observation that among people with type 2 diabetes, those who have high visceral fat with low subcutaneous fat, show increased carotid intima media thickness [36] . This observation is consistent with our finding that obesity combined with low iliac skinfold constitutes a high-risk state and accords with mortality risk being concentrated in deaths from arteriovascular disease. However, whilst depletion of a particular subcutaneous fat depot might imply increased ectopic fat deposition and, therefore, increased arteriovascular risk, there appear to be no precedents for an association between a low subcutaneous fat depot and infection death. Pneumonia was the most common cause of infection death which might indicate a contribution from premature ageing or wasting to the association we observed. However, these considerations do not explain why iliac skinfold alone was associated with increased mortality. In this respect, it is noteworthy that measurement error for the iliac skinfold may be less compared to other skinfolds, especially with increasing obesity levels [37] . Accordingly, iliac skinfold might provide a particularly precise index of subcutaneous fat.
Regardless of underlying mechanisms, it does appear that a low iliac skinfold can indicate particularly unhealthy obesity but whether the pattern of low iliac skinfold and Fig. 1 Increased risk of death in overweight and obese white males with low iliac skinfold thickness. Hazard ratios (HR) and 95% confidence intervals (95%ci) are shown for mortality stratified by quartiles of iliac skinfold: q1 3.3-9.7 mm; q2 9.8-13.7 mm; q3 13.8-20.0 mm relative to q4 > 20.0 mm in normal weight (diamonds), overweight (circles) and obese (squares) individuals. p-values are shown for quartiles in which there was a significant effect high BMI is metabolically unhealthy remains to be established. In our previous analysis of relationships between skinfold thicknesses and arteriovascular disease risk factors in the HDDRISC cohort, variations in age, smoking, alcohol and exercise were taken into account but variation in BMI was not [31] . Accordingly, the associations observed between skinfolds and risk factors were simply those expected with overall adiposity.
Relatively little use has been made of skinfolds in clinical practice, possibly because of an apparent lack of any strong predictive advantage over basic anthropometric measurements such as BMI or waist circumference. Use of ratios might be expected to strengthen independent associations by skinfold measures but our analysis provided little support for this. The subscapular/triceps ratio has been proposed as a CVD-associated marker of central fat deposition [29] but our analysis found no evidence for this ratio having an independent association with cardiovascular mortality. The BMI/iliac ratio might have been expected to provide a sensitive index of mortality risk. However, the ratio proved uninformative, with only a weak negative relationship emerging in multivariable analysis. The positive correlation between BMI and iliac skinfold and their contrasting independent associations with mortality made interpretation of these findings problematic. Therefore, we undertook a more explicit analysis by exploring risks in successive ranges of BMI. This uncovered a marked increase in mortality risk associated an iliac skinfold of 9.7 mm or less among participants with a BMI of 29 kg/m 2 or more, which offers the possibility for a useful clinical index. Exploring this in other cohorts could be worthwhile.
Our study has limitations and strengths. Only white males were studied so the results are not generalisable to other ethnic groups or women. There were relatively small numbers of obese participants (n = 67). Also, there were no direct measurements of adiposity (e.g., MRI or CT) that would have helped us establish how iliac skinfold related to ectopic fat deposition in this cohort. A strength of our study is that it concerned apparently healthy individuals, followed for a long period and with relatively little prescription drug use. Moreover, the restricted selection of participants may have helped to distinguish significant associations. Besides that, the skinfold measurements were carried out by a historically continuous research group working in dedicated clinical research facilities. The long duration of follow-up may have enabled discrimination of effects that shorter duration prospective studies have missed, although with greater numbers of events, it might have been possible to detect non-linearities in the relationships between skinfolds and mortality. Linearity checks revealed a discontinuous relationship whereby a low triceps skinfold was associated with all-cause mortality but this association showed little of the strength and consistency we found for low iliac skinfold and may, therefore have been a chance finding. Our analysis did employ extensive statistical testing, which suggests that some false-positive significances may have been encountered. In principle, five primary hypotheses were explored, namely that biceps, triceps, subscapular and iliac skinfold thicknesses and the subscapular/triceps skinfold ratio were each independently associated with all-cause mortality. A probability of <0.01 (0.05 ÷ 5) is therefore appropriate for rejecting the null hypothesis. The independent association of iliac skinfold with all-cause mortality was significant at p = 0.002 and is, therefore, unlikely to have been a chance finding. We consider further testing in specific mortality groupings and in different ranges of BMI to have been exploratory and hypothesis-generating.
In conclusion, we found that in adult white males, low iliac skinfold thickness is associated with all-cause, arteriovascular and infection mortality independently of BMI. Risk appears to be particularly concentrated in the very overweight and the obese, with a 6-fold increase in all-cause mortality risk above a BMI of 30 kg/m 2 . This observation needs to be confirmed in other cohorts and metabolic and ectopic fat correlates of low iliac skinfold need to be explored further.
